aTyr Pharma has received a second 18-month grant to fund the research being carried out by its Hong Kong subsidiary, Pangu BioPharma. In Hong Kong, aTyr collaborates with the Hong Kong University of Science and Technology (HKUST). The grant, issued by The Innovation and Technology Commission of the Hong Kong government, matches research funds spent by Pangu-HKUST. More details...